QRG Capital Management’s Moderna MRNA Stock Holding History

QRG Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.12M	Buy	15,957 +2,291	+17%	+$119K	0.01%	595
2026 Q1	$694K	Buy	+13,666	New	+$638K	0.01%	679
2025 Q2	–	Sell	-8,274	Closed	-$235K	–	1145
2025 Q1	$235K	Buy	8,274 +1,150	+16%	+$40.8K	﹤0.01%	975
2024 Q4	$296K	Sell	7,124 -8,666	-55%	-$414K	﹤0.01%	907
2024 Q3	$1.06M	Sell	15,790 -20,037	-56%	-$1.84M	0.01%	578
2024 Q2	$4.25M	Sell	35,827 -708	-2%	-$89.6K	0.05%	294
2024 Q1	$3.89M	Sell	36,535 -28,220	-44%	-$2.84M	0.05%	306
2023 Q4	$6.44M	Buy	64,755 +672	+1%	+$56.5K	0.1%	219
2023 Q3	$6.62M	Buy	+64,083	New	+$7.15M	0.11%	194

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

QRG Capital Management's MRNA Position: Q2 2026 in Review

QRG Capital Management increased its Moderna (MRNA) stake by 17% in Q2 2026, buying an estimated $119K and bringing the position to 15,957 shares worth $1.12M. The position accounts for 0.01% of the portfolio, ranked #595.

QRG Capital Management first reported a position in MRNA in Q3 2023 and has held it in 9 quarters since. The position peaked at $6.62M in Q3 2023. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

QRG Capital Management held 15,957 shares of Moderna worth $1.12M as of Q2 2026.
QRG Capital Management bought 2,291 Moderna shares in Q2 2026, an estimated $119K.
Moderna made up 0.01% of QRG Capital Management's portfolio in Q2 2026, its #595 holding.
QRG Capital Management first reported a position in Moderna in Q3 2023 and has held it in 9 quarters since.
QRG Capital Management's Moderna position peaked at $6.62M in Q3 2023.
784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on QRG Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.